Insider Shareholders with Direct Ownership of Nova Bay Pharmaceuticals, Inc. (NBY)
This section provides a comprehensive overview of the insiders with direct ownership of Nova Bay Pharmaceuticals, Inc. (NBY). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
NovaBay Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Andrew D. Jones
CFO |
45,455 | 77,994 | 127,461 $75,201 | 3 |
Dec 06, 2021
Added 22.39%
|
|
Justin Hall
CEO, GC and Director |
79,767 | 0 | 83,172 $49,071 | 2 |
Sep 14, 2022
Added 10.73%
|
|
Swan Sit
Director |
30,858 | 0 | 1,716 $1,012 | 2 |
May 11, 2023
Added 33.33%
|
|
Paul E. Freiman
Director |
30,858 | 0 | 1,716 $1,012 | 2 |
May 11, 2023
Added 33.33%
|
|
Mijia Wu
Director |
30,858 | 0 | 1,716 $1,012 | 2 |
May 11, 2023
Added 33.33%
|
|
Yenyou Zheng
Director |
30,858 | 0 | 1,716 $1,012 | 2 |
May 11, 2023
Added 33.33%
|
|
Yongxiang Zheng
Director |
858 | 0 | 858 $506 | 1 |
May 11, 2023
Added 50.0%
|
|
Julie Garlikov
Director |
858 | 0 | 858 $506 | 1 |
May 11, 2023
Added 50.0%
|